Abstract Library

Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.

Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.

ENETS Abstract Search

#358 Enhanced Combined 177Lu-DOTATATE and 90Y-DOTATATE Treatment of Patients with Metastatic Neuroendocrine Tumors Refractory to Conventional Therapy: An Ongoing Study.

Introduction: Neuroendocrine tumors (NETs) over-express somatostatin receptors (SRs) and the efficacy of peptide receptor radionuclide therapy (PRRT) with somatostatin analogues labeled with high activities of ß-emitting radioisotopes have been reported.

Conference:

Presenting Author:

Authors: Mallia A, Seregni E, Maccauro M, Chiesa C, Coliva A,

Keywords: Neuroendocrine tumors,peptide receptor radionuclide therapy. Study is partially supported by a grant from the Min.of Health (5 per mille) and Italian Association of Cancer (AIRC).,